Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Chéron M[au]:

[Using negative pressure therapy to prevent and treat wounds]. Nicodème M et al. Soins. (2017)

Community-acquired Clostridium difficile infections in emergency departments. Lefevre-Tantet-Etchebarne D et al. Med Mal Infect. (2016)

Development of antileishmanial lipid nanocomplexes. Pham TT et al. Biochimie. (2014)

Search results

Items: 40

1.

[Support care in paediatric oncology].

Cheron M, Jezequel T, Boscaro M, Consani D.

Rev Infirm. 2019 Nov;68(255):29-30. doi: 10.1016/j.revinf.2019.09.007. French.

PMID:
31757326
2.

Osmotic 'cost' of reproduction in breeding male toads.

Brischoux F, Cheron M.

Biol Lett. 2019 Nov 29;15(11):20190689. doi: 10.1098/rsbl.2019.0689. Epub 2019 Nov 13.

PMID:
31718512
3.

Acellular fish skin matrix on thin-skin graft donor sites: a preliminary study.

Badois N, Bauër P, Cheron M, Hoffmann C, Nicodeme M, Choussy O, Lesnik M, Poitrine FC, Fromantin I.

J Wound Care. 2019 Sep 2;28(9):624-628. doi: 10.12968/jowc.2019.28.9.624.

PMID:
31513492
4.

Life-threatening acute airway obstruction induced by unsuspected achalasia.

Desprez C, Netchitaïlo M, Cheron M, Gourcerol G, Melchior C.

Clin Res Hepatol Gastroenterol. 2019 Nov;43(6):e87-e89. doi: 10.1016/j.clinre.2019.03.003. Epub 2019 Apr 5. No abstract available.

PMID:
30956124
5.

Reaching the unreached: Performance of an enhanced peer outreach approach to identify new HIV cases among female sex workers and men who have sex with men in HIV programs in West and Central Africa.

Lillie TA, Persaud NE, DiCarlo MC, Gashobotse D, Kamali DR, Cheron M, Nishimoto L, Akolo C, Mahler HR, Au MC, Wolf RC.

PLoS One. 2019 Apr 3;14(4):e0213743. doi: 10.1371/journal.pone.0213743. eCollection 2019.

6.

Effect of high pressure homogenization on the structure and the interfacial and emulsifying properties of β-lactoglobulin.

Ali A, Le Potier I, Huang N, Rosilio V, Cheron M, Faivre V, Turbica I, Agnely F, Mekhloufi G.

Int J Pharm. 2018 Feb 15;537(1-2):111-121. doi: 10.1016/j.ijpharm.2017.12.019. Epub 2017 Dec 12.

PMID:
29241702
7.

[Using negative pressure therapy to prevent and treat wounds].

Nicodème M, Chéron M, Fromantin I.

Soins. 2017 Nov;62(820):14-17. doi: 10.1016/j.soin.2017.09.001. French.

8.

Community-acquired Clostridium difficile infections in emergency departments.

Lefevre-Tantet-Etchebarne D, Sivadon-Tardy V, Davido B, Bouchand F, Grenet J, Farfour E, Getti R, Duran C, Chéron M, Mathieu E, Salomon J, Dinh A.

Med Mal Infect. 2016 Oct;46(7):372-379. doi: 10.1016/j.medmal.2016.06.002. Epub 2016 Jul 1.

PMID:
27377443
9.

Case-based learning and multiple choice questioning methods favored by students.

Chéron M, Ademi M, Kraft F, Löffler-Stastka H.

BMC Med Educ. 2016 Feb 2;16:41. doi: 10.1186/s12909-016-0564-x.

10.

First enantioselective total synthesis and configurational assignments of suberosenone and suberosanone as potential antitumor agents.

Kousara M, Ferry A, Le Bideau F, Serré KL, Chataigner I, Morvan E, Dubois J, Chéron M, Dumas F.

Chem Commun (Camb). 2015 Feb 25;51(16):3458-61. doi: 10.1039/c4cc10041g.

PMID:
25626720
11.

Development of antileishmanial lipid nanocomplexes.

Pham TT, Gueutin C, Cheron M, Abreu S, Chaminade P, Loiseau PM, Barratt G.

Biochimie. 2014 Dec;107 Pt A:143-53. doi: 10.1016/j.biochi.2014.06.007. Epub 2014 Jun 18.

PMID:
24952352
12.

Development of oil-in-water microemulsions for the oral delivery of amphotericin B.

Silva AE, Barratt G, Chéron M, Egito ES.

Int J Pharm. 2013 Oct 1;454(2):641-8. doi: 10.1016/j.ijpharm.2013.05.044. Epub 2013 May 31.

13.

Bivalent sequential binding of docetaxel to methyl-β-cyclodextrin.

Mazzaferro S, Bouchemal K, Gallard JF, Iorga BI, Cheron M, Gueutin C, Steinmesse C, Ponchel G.

Int J Pharm. 2011 Sep 15;416(1):171-80. doi: 10.1016/j.ijpharm.2011.06.034. Epub 2011 Jun 25.

PMID:
21736931
14.

The contribution of Raman scattering to the fluorescence of the polyene antibiotic amphotericin B.

Bolard J, Chéron M, Cleary JD, Kramer RE.

J Fluoresc. 2011 Mar;21(2):831-4. doi: 10.1007/s10895-010-0768-0. Epub 2010 Nov 20.

PMID:
21103914
15.

Cyclodextrin and polysaccharide-based nanogels: entrapment of two hydrophobic molecules, benzophenone and tamoxifen.

Daoud-Mahammed S, Couvreur P, Bouchemal K, Chéron M, Lebas G, Amiel C, Gref R.

Biomacromolecules. 2009 Mar 9;10(3):547-54. doi: 10.1021/bm801206f.

PMID:
19173558
16.

Modulation of polyene antibiotics self-association by ions from the Hofmeister series.

Toledo Grijalba M, Chéron M, Borowski E, Bolard J, Schreier S.

Biochim Biophys Acta. 2006 Jun;1760(6):973-9. Epub 2006 Mar 3.

PMID:
16563634
17.

New lipid formulation of amphotericin B: spectral and microscopic analysis.

Larabi M, Gulik A, Dedieu JP, Legrand P, Barratt G, Cheron M.

Biochim Biophys Acta. 2004 Aug 30;1664(2):172-81.

18.

Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals.

Cartolano GL, Cheron M, Benabid D, Leneveu M, Boisivon A; Association of Hospital Bacteriologists, Virologists and Hygiene Professionals.

Clin Microbiol Infect. 2004 May;10(5):448-51.

19.

Evidence for restrictive parameters in formulation of insulin-loaded nanocapsules.

Cournarie F, Chéron M, Besnard M, Vauthier C.

Eur J Pharm Biopharm. 2004 Mar;57(2):171-9.

PMID:
15018972
20.

Does fluorescence spectroscopy detect dimers of the polyene antibiotic amphotericin B?

Bolard J, Chéron M.

J Photochem Photobiol B. 2003 Dec 5;72(1-3):101-2; author reply 103-5. No abstract available.

PMID:
14644572
21.

Heat-induced reformulation of amphotericin B-deoxycholate favours drug uptake by the macrophage-like cell line J774.

Chéron M, Petit C, Bolard J, Gaboriau F.

J Antimicrob Chemother. 2003 Dec;52(6):904-10. Epub 2003 Nov 12.

PMID:
14613963
22.

Polymeric carriers for amphotericin B: in vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice.

Espuelas MS, Legrand P, Campanero MA, Appel M, Chéron M, Gamazo C, Barratt G, Irache JM.

J Antimicrob Chemother. 2003 Sep;52(3):419-27. Epub 2003 Jul 29.

PMID:
12888593
23.

Effect of camphor/cyclodextrin complexation on the stability of O/W/O multiple emulsions.

Yu SC, Bochot A, Bas GL, Chéron M, Mahuteau J, Grossiord JL, Seiller M, Duchêne D.

Int J Pharm. 2003 Aug 11;261(1-2):1-8.

PMID:
12878390
24.

Combined hydroxypropyl-beta-cyclodextrin and poly(alkylcyanoacrylate) nanoparticles intended for oral administration of saquinavir.

Boudad H, Legrand P, Lebas G, Cheron M, Duchêne D, Ponchel G.

Int J Pharm. 2001 May 7;218(1-2):113-24.

PMID:
11337155
25.

[Primary Neisseria meningitidis arthritis of the knee without meningitis: contribution of synovial fluid culture in blood-culture vial].

Cartolano GL, Le Lostec Z, Chéron M, Boisivon A, Welker Y, Mornet P.

Rev Med Interne. 2001 Jan;22(1):75-8. French.

PMID:
11218303
26.

Lymph node infection by Trichomonas tenax: report of a case with co-infection by Mycobacterium tuberculosis.

Duboucher C, Farto-Bensasson F, Chéron M, Peltier JY, Beaufils F, Périé G.

Hum Pathol. 2000 Oct;31(10):1317-21.

PMID:
11070125
27.

N-Methyl-N-D-fructosyl amphotericin B methyl ester (MF-AME), a novel antifungal agent of low toxicity: monomer/micelle control over selective toxicity.

Cybulska B, Gadomska I, Mazerski J, Borowski JGE, Cheron M, Bolard J.

Acta Biochim Pol. 2000;47(1):121-31.

28.

In-vivo therapeutic efficacy in experimental murine mycoses of a new formulation of deoxycholate-amphotericin B obtained by mild heating.

Petit C, Chéron M, Joly V, Rodrigues JM, Bolard J, Gaboriau F.

J Antimicrob Chemother. 1998 Dec;42(6):779-85.

PMID:
10052902
29.

Probable transmission of HIV from an orthopedic surgeon to a patient in France.

Lot F, Séguier JC, Fégueux S, Astagneau P, Simon P, Aggoune M, van Amerongen P, Ruch M, Cheron M, Brücker G, Desenclos JC, Drucker J.

Ann Intern Med. 1999 Jan 5;130(1):1-6.

PMID:
9890844
30.

Heat-induced superaggregation of amphotericin B reduces its in vitro toxicity: a new way to improve its therapeutic index.

Gaboriau F, Chéron M, Petit C, Bolard J.

Antimicrob Agents Chemother. 1997 Nov;41(11):2345-51.

31.

Physico-chemical properties of the heat-induced 'superaggregates' of amphotericin B.

Gaboriau F, Chéron M, Leroy L, Bolard J.

Biophys Chem. 1997 May 21;66(1):1-12.

PMID:
17029866
32.

Reduced susceptibility to quinolones in Salmonella typhi acquired in Europe: a clinical failure of treatment.

Le Lostec Z, Fegueux S, Jouve P, Cheron M, Mornet P, Boisivon A.

Clin Microbiol Infect. 1997;3(5):576-577. No abstract available.

33.

Release of amphotericin B from delivery systems and its action against fungal and mammalian cells.

Legrand P, Chéron M, Leroy L, Bolard J.

J Drug Target. 1997;4(5):311-9.

PMID:
9169988
34.
35.

In vitro renal toxicity and in vivo therapeutic efficacy in experimental murine cryptococcosis of amphotericin B (Fungizone) associated with Intralipid.

Joly V, Farinotti R, Saint-Julien L, Chéron M, Carbon C, Yeni P.

Antimicrob Agents Chemother. 1994 Feb;38(2):177-83.

36.

Quantitative structure-activity relationships in amphotericin B derivatives.

Chéron M, Cybulska B, Mazerski J, Grzybowska J, Czerwiński A, Borowski E.

Biochem Pharmacol. 1988 Mar 1;37(5):827-36.

PMID:
3278711
37.

Inhibition by Cu2+ of amphotericin B induced lysis of erythrocytes.

Chéron M, Bolard J, Brajtburg J.

FEBS Lett. 1984 Dec 3;178(1):127-31.

39.
40.

[Incorporation of (3R,3'R)zeaxanthin in vesicles of dipalmitoyl phosphatidylcholine. Circular dichroism analysis].

Chéron M, Bolard J.

C R Seances Acad Sci III. 1981 Jun 15;292(21):1125-8. French.

PMID:
6791778

Supplemental Content

Loading ...
Support Center